BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10618707)

  • 1. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
    Vaziri H; Benchimol S
    Oncogene; 1999 Dec; 18(53):7676-80. PubMed ID: 10618707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
    Wadhwa R; Takano S; Taira K; Kaul SC
    J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical telomere shortening regulated by the ataxia-telangiectasia gene acts as a DNA damage signal leading to activation of p53 protein and limited life-span of human diploid fibroblasts. A review.
    Vaziri H
    Biochemistry (Mosc); 1997 Nov; 62(11):1306-10. PubMed ID: 9467855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition.
    Xu HJ; Zhou Y; Ji W; Perng GS; Kruzelock R; Kong CT; Bast RC; Mills GB; Li J; Hu SX
    Oncogene; 1997 Nov; 15(21):2589-96. PubMed ID: 9399646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence and immortalization: role of telomeres and telomerase.
    Shay JW; Wright WE
    Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase, checkpoints and cancer.
    Harley CB; Sherwood SW
    Cancer Surv; 1997; 29():263-84. PubMed ID: 9338104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides.
    Li GZ; Eller MS; Hanna K; Gilchrest BA
    Exp Cell Res; 2004 Dec; 301(2):189-200. PubMed ID: 15530855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase and human tumorigenesis.
    Stewart SA; Weinberg RA
    Semin Cancer Biol; 2000 Dec; 10(6):399-406. PubMed ID: 11170862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
    Goodwin EC; DiMaio D
    Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.
    MacKenzie KL; Franco S; May C; Sadelain M; Moore MA
    Exp Cell Res; 2000 Sep; 259(2):336-50. PubMed ID: 10964501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
    Duan J; Chen Z; Liu P; Zhang Z; Tong T
    Int J Oncol; 2004 Jun; 24(6):1597-605. PubMed ID: 15138605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy.
    Preto A; Singhrao SK; Haughton MF; Kipling D; Wynford-Thomas D; Jones CJ
    Oncogene; 2004 May; 23(23):4136-45. PubMed ID: 15064743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple pathways to cellular senescence: role of telomerase repressors.
    Oshimura M; Barrett JC
    Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
    Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
    Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase.
    Morales CP; Holt SE; Ouellette M; Kaur KJ; Yan Y; Wilson KS; White MA; Wright WE; Shay JW
    Nat Genet; 1999 Jan; 21(1):115-8. PubMed ID: 9916803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase, senescence and ageing.
    Shawi M; Autexier C
    Mech Ageing Dev; 2008; 129(1-2):3-10. PubMed ID: 18215413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere dynamics and telomerase activity in in vitro immortalised human cells.
    Bryan TM; Reddel RR
    Eur J Cancer; 1997 Apr; 33(5):767-73. PubMed ID: 9282115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53.
    Maehara K; Yamakoshi K; Ohtani N; Kubo Y; Takahashi A; Arase S; Jones N; Hara E
    J Cell Biol; 2005 Feb; 168(4):553-60. PubMed ID: 15716376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage response, checkpoint activation and dysfunctional telomeres: face to face between mammalian cells and Drosophila.
    Cipressa F; Cenci G
    Tsitologiia; 2013; 55(4):211-7. PubMed ID: 23875450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senescence mechanisms of nucleus pulposus chondrocytes in human intervertebral discs.
    Kim KW; Chung HN; Ha KY; Lee JS; Kim YY
    Spine J; 2009 Aug; 9(8):658-66. PubMed ID: 19540815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.